Pharmacy groups’ motion for preliminary injunction denied in Medco-Express Scripts case
U.S. District Judge Cathy Bissoon has denied a motion for preliminary injunction raised by retail pharmacy groups challenging Express Scripts’ purchase of Medco Health Solutions. Judge Bissoon found that plaintiffs were unable to show the likelihood of immediate, irreparable harm. The harm that they did allege–displaced management and the exchange of confidential information and trade secrets between Medco and Express Scripts–was found to have already happened because of the two companies’ integration plan of July 2011. Morever, Judge Bissoon found that a temporary injunction would render Medco unable to compete with Express Scripts, as nearly all of Medco’s senior management has already been terminated.
Featured News
Newsom Signs Sweeping California Data Center Oversight Package
Sep 21, 2026 by
CPI
Frozen-Potato Producers Must Face Most Price-Fixing Claims, Judge Rules
Sep 21, 2026 by
CPI
Paramount Reaches Deal With States, Clearing Major Hurdle to Warner Bros. Takeover
Sep 21, 2026 by
CPI
Russia Opens Antitrust Cases Over Generic Versions of Pfizer’s Eliquis
Sep 21, 2026 by
CPI
Google Faces €403 Million EU Privacy Penalty Over Location Tracking
Sep 21, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton